eISSN: 2978-3747 editor@irjernet.com
All Journals
Submit your article

Instruction For Authors

Instruction For Authors

Frontiers in Medical and Clinical Sciences (FMCS)

eISSN: 2978-3747

1. About the Journal

Frontiers in Medical and Clinical Sciences (FMCS) is an international, double-blind peer-reviewed, Open Access scholarly journal dedicated to publishing high-quality, impactful research that advances medical science, clinical practice, translational research, and healthcare outcomes globally.

FMCS provides an inclusive global platform for medical researchers, clinicians, physicians, surgeons, epidemiologists, and healthcare professionals to disseminate original empirical research, critical systematic reviews, and novel clinical insights addressing contemporary challenges in global medicine.

2. Scope and Acceptable Topics

The journal welcomes high-quality submissions across basic medical sciences, clinical disciplines, and healthcare sciences, covering (but not limited to) the following core focus areas:

  • General Medicine, Internal Medicine, & Family Healthcare

  • Cardiology, Cardiovascular Diseases, & Vascular Surgery

  • Oncology, Cancer Biology, & Hematology

  • Neurology, Neurosurgery, & Neurosciences

  • Gastroenterology, Hepatology, & Endocrinology

  • Immunology, Infectious Diseases, & Microbiology

  • Surgery, Anesthesiology, & Intensive Care Medicine

  • Pediatrics, Neonatology, & Adolescent Medicine

  • Obstetrics, Gynecology, & Women’s Health

  • Radiology, Medical Imaging, & Radiotherapy

  • Pathology, Histopathology, & Laboratory Medicine

  • Epidemiology, Public Health, & Global Health Policy

  • Pharmacology, Toxicology, & Clinical Therapeutics

3. Acceptable Article Types

FMCS publishes several distinct categories of medical and scholarly contributions:

  • Original Research Articles: Full-length empirical studies, clinical trials, or experimental work presenting novel findings, robust methodology, clear statistical analysis, and direct clinical implications.

  • Review Articles: Systematic reviews, meta-analyses, and comprehensive critical evaluations of existing medical literature or emerging clinical guidelines.

  • Case Reports & Case Series: Detailed reports of unique, rare, or clinically instructive cases that offer novel diagnostic or therapeutic insights.

  • Short Communications & Brief Reports: Preliminary research findings, urgent clinical observations, or novel methodological developments requiring rapid publication.

  • Editorials & Opinion Papers: Expert commentaries on pressing global health issues, controversial medical practices, or policy updates.

4. Pre-Submission Checklist

Before submitting a manuscript, authors must verify full compliance with the following mandatory requirements:

  • Originality: The manuscript represents entirely original research and has not been published previously in any form or language.

  • Exclusivity: The manuscript is not currently under consideration by any other journal, book chapter, or conference platform.

  • Author Approvals: All listed co-authors have reviewed, approved, and explicitly agreed to the final manuscript version.

  • Ethical Approvals (IRB/Ethics Board): Studies involving human subjects or animal models must state approval from an appropriate institutional ethics committee or Institutional Review Board (IRB).

  • Informed Consent: Signed written informed consent must be documented for any clinical studies involving human subjects or identifiable patient data.

  • Plagiarism & Similarity Index: The manuscript adheres to strict publication ethics and maintains a similarity index below the acceptable journal threshold (<15% overall, excluding references and standard clinical terminology).

5. Manuscript Preparation Guidelines

A. General Formatting

  • File Format: Microsoft Word (.doc or .docx) format only.

  • Language: Academic and medical English (clear, concise, and grammatically precise).

  • Font & Size: Times New Roman, 12 pt size.

  • Line Spacing: 1.5 line spacing throughout the entire document.

  • Margins: Standard 2.5 cm (1 inch) on all sides.

  • Page Numbers: Consecutive numbering centered at the bottom of each page.

B. Recommended Manuscript Structure

Title Page (Uploaded Separately for Double-Blind Review)

  • Concise, informative title free of unnecessary jargon or non-standard abbreviations.

  • Full names, institutional affiliations, city, and country of all authors.

  • ORCID iDs for all contributing authors.

  • Corresponding author’s official email address and telephone contact details.

Main Body (Anonymized for Double-Blind Review)

  • Abstract: Structured summary (150–250 words) divided into: Background/Objective, Methods, Results, and Conclusion.

  • Keywords: 4 to 6 relevant medical terms (preferably utilizing Medical Subject Headings - MeSH terms).

  • Main Text (IMRaD Framework):

    • Introduction: Research rationale, clinical gap, literature context, and precise study objectives.

    • Methods: Detailed study design, participant selection criteria, ethical approvals, clinical procedures, experimental techniques, and statistical tests employed.

    • Results: Objective presentation of quantitative/qualitative findings supported by clear tables and high-resolution figures.

    • Discussion: Interpretation of findings in relation to existing literature, clinical significance, theoretical/practical contributions, study limitations, and future directions.

    • Conclusion: Clear, concise summary highlighting key clinical takeaways.

  • Declarations & Statements:

    • Ethical Approval & Informed Consent Statement: IRB approval numbers and consent details.

    • Funding Statement: Full details of research grants, pharmaceutical support, or institutional funding.

    • Conflict of Interest Declaration: Explicit disclosure of any financial, personal, or clinical competing interests.

    • Data Availability Statement: Explanation of where raw, anonymized clinical data can be accessed.

    • Author Contributions: Detailed statement outlining individual contributions according to ICMJE criteria.

  • Acknowledgements: (If applicable) Technical assistance, language editing, or administrative support.

  • References: Formatted strictly in standard Vancouver or AMA medical citation style. Active Digital Object Identifiers (DOIs) must be included for all cited references where available.

  • Tables & Figures: Embedded directly within the main text near their first mention, accompanied by descriptive captions and high-resolution clarity (300 DPI minimum for images/scans).

6. Peer Review & Editorial Process

FMCS enforces a rigorous Double-Blind Peer Review process to safeguard scientific objectivity and clinical rigor:

  1. Initial Desk Review: The Editorial Office evaluates submissions for scope alignment, formatting compliance, ethics compliance, and plagiarism checks (Turnitin/iThenticate).

  2. Double-Blind External Review: Submissions passing desk evaluation are assigned to at least two independent clinical experts in the relevant field without revealing author or reviewer identities.

  3. Editorial Decision: Based on reviewer evaluations, the Handling Editor / Editor-in-Chief issues one of five formal decisions:

    • Accept without Revision

    • Minor Revisions Required

    • Major Revisions Required (Subject to re-evaluation)

    • Reject with Opportunity for Resubmission

    • Reject

7. Artificial Intelligence (AI) Policy

  • Authors may use Artificial Intelligence (AI) tools solely for language translation, basic grammar improvement, or readability refinement.

  • AI tools cannot be listed as an author or co-author under any circumstances, as they do not meet ICMJE/COPE authorship eligibility criteria.

  • Authors must explicitly declare the use of AI tools in the Methods or Acknowledgments section and remain 100% accountable for the scientific accuracy, integrity, and originality of the content.

8. Open Access, Copyright & Article Processing Charge (APC)

  • Open Access: All published articles are made freely and permanently accessible online to readers, clinicians, and researchers worldwide immediately upon publication without restriction.

  • Copyright Retention: Authors retain 100% full copyright of their published work licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

  • Submission Fee: USD $0 (No charges for submitting or undergoing peer review).

  • Article Processing Charges (APC): An Article Processing Charge (APC) is applicable only after a manuscript successfully completes double-blind peer review and receives formal editorial acceptance for publication. The APC covers professional copyediting, typesetting, DOI registration, and permanent digital archiving.

  • Waiver Policy: Partial or full APC waivers are available for authors from low-income countries or those experiencing genuine financial hardship, ensuring financial constraints never hinder quality research publication.

9. Manuscript Submission & Editorial Contact

Manuscripts must be submitted online through the journal's official publishing platform:

  • Official Submission Link: https://forms.gle/RnTZmJziPripPk7u9

  • Editorial Assistance: For queries regarding manuscript preparation, review status, or technical support, please contact the Editorial Office at editor@irjernet.com.